Artisan Partners
PTCT icon

Artisan Partners’s PTC Therapeutics PTCT Stock Holding History

Artisan Partners’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-491,813
Closed -$25M – 344
2020
Q2 		$25M Buy
+491,813
New +$24.2M 0.04% 251
2016
Q1 		– Sell
-340,943
Closed -$11M – 372
2015
Q4 		$11M Sell
340,943
-11,015
-3% -$324K 0.02% 264
2015
Q3 		$9.4M Buy
351,958
+6,610
+2% +$283K 0.02% 285
2015
Q2 		$16.6M Buy
345,348
+162,324
+89% +$9.47M 0.03% 238
2015
Q1 		$11.1M Buy
+183,024
New +$11.2M 0.02% 294

Other funds holding PTCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Artisan Partners's PTCT Position: Q3 2020 in Review

Artisan Partners sold out of PTC Therapeutics (PTCT) in Q3 2020, closing a stake of 491,813 shares — an estimated $25M sold.

Artisan Partners first reported a position in PTCT in Q1 2015 and held it in 5 quarters. The position peaked at $25M in Q2 2020. 197 funds tracked by Wall St. Rank hold PTCT as of Q3 2020.

  • Artisan Partners reported no remaining PTC Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Artisan Partners sold 491,813 PTC Therapeutics shares in Q3 2020, an estimated $25M.
  • Artisan Partners first reported a position in PTC Therapeutics in Q1 2015 and held it in 5 quarters.
  • Artisan Partners's PTC Therapeutics position peaked at $25M in Q2 2020.
  • 197 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2020.

Based on Artisan Partners's 13F filing for Q3 2020, filed 12 Nov 2020.